Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Using 18F-FAPI PET to Evaluate Pathologic Response to Systemic Treatment in Pancreatic Adenocarcinoma

NCT06277206 is registered in ClinicalTrials.gov with Zhejiang University as lead sponsor.

NCT NCT06277206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06277206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Using 18F-FAPI PET to Evaluate Pathologic Response to Systemic Treatment in Pancreatic Adenocarcinoma
Lead sponsor
Zhejiang University
Phase
Observational
Overall status
Completed
Start date
August 4, 2021
Completion date
February 10, 2024
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

18f-fapi, pancreas adenocarcinoma, pathologic response, systemic treatment